GA-AGCO
AGCO Corporation (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, received ten AE50 Awards from the American Society of Agricultural and Biological Engineers (ASABE) for 2023. Each year, an international panel of engineering experts recognizes the year’s 50 most innovative designs in engineering products or systems for the food and agriculture industries. AGCO’s ten AE50 awards span the company’s strong brand portfolio, including Fendt, Fuse, Intelligent Ag, Massey Ferguson, and Precision Planting.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221213005076/en/
AGCO Corp. won ten 2023 AE50 Awards from ASABE for innovative design in engineering products or systems for agriculture. AGCO’s awards span the company’s strong brand portfolio, including Fendt, Fuse, Intelligent Ag, Massey Ferguson, and Precision Planting. Pictured above are the AE50 Award-winning Massey Ferguson WR Series Windrower and Fendt 700 Gen7 Vario tractor.(Photo: Business Wire)
“Innovation is core to our vision of being farmers’ most trusted partner for industry-leading, smart farming solutions and we’re honored to be recognized with ten AE50 Awards across our brand portfolio,” said Eric Hansotia, AGCO chairman, president, and chief executive officer. “Helping farmers maximize yield while reducing inputs and impact delivers real value to farmers and motivates our team to accelerate the pace of farmer-first innovation in every area of our business.”
The Fendt® 700 Gen7 Vario® is the brand’s most popular workhorse tractor. Redesigned to improve performance, reduce costs, and increase productivity, the tractor is one of the most versatile and operator-friendly tractors in its market segment with five models ranging from 203 to 283 engine hp, a standard VarioDrive™ CVT, FendtONE™ operators’ station, fuel-efficient AGCO Power™ 7.5L engine, and agronomic-boosting features such as the VarioGrip™ Central Tire Inflation System (CTIS).
Geo-Bird® from Fuse® is a free and intuitive web app that automatically optimizes waylines for multiple fields and implements, saving farmers time and money and supporting greater sustainability. Controlled Traffic Farming (CTF) waylines help farmers reduce time and cost requirements; turns, wheel traffic, and headland overlap; fuel usage and CO2 footprints; and yield-robbing soil compaction. Geo-Bird’s waylines are exportable to terminals of multiple brands for greater ease of use across disparate operations.
The Pit Level Monitor Model AP-6010 from AP (Automated Production®) uses electronic pressure transducers to efficiently measure effluent depth in manure pits below swine confinement facilities. This innovation provides swine facility operators with more accurate management information regarding manure pits, including early warnings of water leakage and remaining storage capacities.
The Massey Ferguson® LB2200 Series Large Square Baler merges the reliability of previous models with new cutting-edge technology advancements. A new pickup design improves baler feeding and parts reliability, while also reducing noise. New axle and tire offerings with a single bogie suspension improve ground clearance and rideability. Common Electric Architecture (CEA) provides greater information and control via ISOBUS terminal for Tractor Implement Management (TIM), bale length, bale eject, and bale chute fold.
The Massey Ferguson® WR Series Windrower provides up to 282 peak horsepower and an industry-exclusive closed-center hydraulic system for increased fuel efficiency and available header horsepower. This also eliminates the need for a secondary pump for auxiliary functions such as a triple windrow attachment (TWA). Technology updates improve field efficiency, reduce operator stress, and allow real-time tracking and data management. MF Guide ensures accurate auto-steering to minimize pass-to-pass overlap. Optional rear steer is available for road transport speeds up to 24.5 mph.
Recon SpraySense™ from Intelligent Ag™ is a retrofit sprayer product that measures pressure and flow at each nozzle to help ensure applications match targeted coverage and rates. GPS capability and a database of nozzles from major manufacturers infer accurate droplet size. Each nozzle’s performance is condensed as a single Spray Quality Score and provided to operators via an iPad application. Recon SpraySense is a turn-key solution and provides state-of-the-art technology on sprayers old and new.
ReClaim™ from Precision Planting® replaces nozzle bar endcaps in sprayers and provides a return path back to the tank for improved product agitation and circulation, faster boom priming, and improved boom cleanout. ReClaim also improves sprayer cleanout with compressed air that pushes product back to the tank where it is drained and properly disposed. These improvements reduce build-up in the boom, product waste on the ground, and crop damage from misapplication.
Precision Planting’s Radicle Agronomics™ is the world’s first, fully-automated soil laboratory. Its small footprint, self-calibration technology, and ability to run hundreds of unattended samples, replaces manual, error-prone processes and provides tremendous efficiency and improved accuracy to professional agronomists. Cloud-based software connects all steps of the field-to-lab process so agronomists can deliver superior nutrient management recommendations to their clients.
Precision Planting’s EM HD is a new liquid fertilizer controller and sensor that uses an electromagnetic flow sensor to provide row-by-row, high-speed liquid fertilizer rate control on row crop planters, side-dress implements, and strip-till implements. Immediate feedback from the flow sensor allows the system to make high-speed changes to the liquid valve control, which maintains a more accurate and consistent flow of fertilizer to the implement’s application point.
Precision Planting’s Blockage Expansion Module (BXM) is a monitoring component for non-singulated crop seeding implements that combines and connects multiple blockage sensors into a single connection point for 20|20 seed monitoring systems. By simplifying the implement’s electronic components and providing more user-friendly and actionable data, BXM improves the growers' ability to diagnose issues arising in the delivery of products from the commodity tanks to the application point.
For more information on these AE50 award-winning products, visit your nearest AGCO dealer, the links above, or AGCOcorp.com.
Online Version
An online version of this announcement with media downloads is available HERE.
Fendt, Fuse, Geo-Bird, Massey Ferguson, Precision Planting, and Vario are registered trademarks of AGCO. AGCO Power, FendtONE, Intelligent Ag, Radicle Agronomics, Recon SpraySense, VarioDrive, and VarioGrip are trademarks of AGCO.
About AGCO
AGCO (NYSE:AGCO) is a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology. AGCO delivers customer value through its differentiated brand portfolio including core brands like Challenger®, Fendt®, GSI®, Massey Ferguson®, Precision Planting® and Valtra®. Powered by Fuse® smart farming solutions, AGCO’s full line of equipment and services help farmers sustainably feed our world. Founded in 1990 and headquartered in Duluth, Georgia, USA, AGCO had net sales of approximately $11.1 billion in 2021. For more information, visit www.AGCOcorp.com. For company news, information and events, please follow us on Twitter: @AGCOCorp. For financial news on Twitter, please follow the hashtag #AGCOIR.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221213005076/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom